GlassScriptPhysician profile
Robert K Ritchey
NPI 1093763831
$879.47
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $171 · 2021: $74.24 · 2022: $112 · 2023: $257 · 2024: $266.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $523.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $522.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $191.64 | 2019-2024 | |
| Novo Nordisk INC | $119.22 | 2019-2024 | Wegovy |
| Lilly USA, LLC | $75.32 | 2023-2024 | Mounjaro, Jardiance, Zepbound |
| Glaxosmithkline, LLC. | $64.32 | 2022-2024 | Shingrix, Trelegy Ellipta, Arexvy |
| Biohaven Pharmaceutical Holding Company LTD. | $56.27 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $50.95 | 2019 | |
| Amgen INC. | $46.05 | 2019-2023 | Repatha, Otezla |
| Boehringer Ingelheim Pharmaceuticals, INC. | $37.60 | 2021-2022 | |
| Astellas Pharma US INC | $33.47 | 2024 | Veozah |
| Sanofi Pasteur INC. | $29.00 | 2023 | |
| Gilead Sciences, INC. | $28.53 | 2024 | Epclusa |
| Janssen Pharmaceuticals, INC | $26.70 | 2019 | |
| Exact Sciences Corporation | $24.52 | 2023 | Cologuard Collection Kit |
| Kowa Pharmaceuticals America, INC. | $18.55 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $18.53 | 2023 | Trulance, Xifaxan |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $18.12 | 2021 | |
| Kyowa Kirin, INC. | $16.26 | 2023 | Crysvita |
| Astrazeneca Pharmaceuticals LP | $12.60 | 2019 | |
| Merck Sharp & Dohme LLC | $11.82 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Ritchey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.